DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, Lubricant, Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" report to their offering.
The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021.
The market is mainly driven by emergence of new excipients for the pharmaceutical industry, growing generic drugs market, developments in nanotechnology, and growing global pharmaceutical market. Emerging markets such as India and China and the increasing demand for multi-functionality excipients will provide growth opportunities for major players in the market.
In this report, the global pharmaceutical excipients market is segmented by product, by delivery mode, by functionality, and by region. The pharmaceutical excipients market is classified by product into inorganic chemicals, organic chemicals, and other chemicals. Organic chemicals are further divided into carbohydrates, petrochemicals, oleochemicals, proteins, and others. On the basis of delivery mode, the market is further subsegmented into oral formulations, topical formulations, parenteral formulations, and advanced delivery systems.
Oral formulations, by delivery mode, include tablets, capsules, and liquid formulations. By functionality, the pharmaceutical excipients market is divided into fillers & diluents, binders, suspension & viscosity agents, coatings, flavoring agents, disintegrants, colorants, lubricants & glidants, and preservatives.
The fillers & diluents segment accounted for the largest share of the pharmaceutical excipients market, by functionality, in 2015 and is expected to continue to dominate the market in 2021. However, the lubricant & glidants segment will witness the highest growth. From the manufacturer's perspective, fillers and diluents offer stability, ease in preparation, packaging, shipping, and dispensing; for patients, they improve the taste of the formulation and provide ease of administration (of the drug). The fillers and diluents market is expected to grow due to the increased use of fillers and diluents in the development and production of solid oral drugs.
Europe dominated the global pharmaceutical excipients market in 2015, followed by North America. Developed geographies like Europe and North America and are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The rapid growth in the Asia-Pacific region is largely driven by the growth in research activities and emerging market for pharmaceutical manufacturing.
The major players in the pharmaceutical excipients market include Ashland, Inc. (U.S.), BASF SE (Germany), the Dow Chemical Company (U.S.), Roquette (France), FMC Corporation (U.S.), Evonik Industries AG (Germany), Associated British Foods Plc. (U.K.), Archer Daniels Midland Company (U.S.), Lubrizol Corporation (U.S.), and Croda International Plc. (U.K.).
For more information visit http://www.researchandmarkets.com/research/wjh58j/pharmaceutical
